NFA
BIO icon

Nationwide Fund Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nationwide Fund Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-96,138
Closed -$21.4M – 264
2017
Q3 		$21.4M Buy
96,138
+4,856
+5% +$1.09M 0.08% 286
2017
Q2 		$20.7M Buy
91,282
+20,803
+30% +$4.53M 0.08% 300
2017
Q1 		$14M Sell
70,479
-17,779
-20% -$3.42M 0.06% 487
2016
Q4 		$16.1M Sell
88,258
-1,055
-1% -$180K 0.07% 395
2016
Q3 		$14.6M Sell
89,313
-11,632
-12% -$1.77M 0.06% 439
2016
Q2 		$14.4M Sell
100,945
-4,087
-4% -$583K 0.06% 427
2016
Q1 		$14.4M Buy
105,032
+3,984
+4% +$523K 0.06% 413
2015
Q4 		$14M Buy
101,048
+8,507
+9% +$1.18M 0.06% 423
2015
Q3 		$12.4M Buy
92,541
+5,753
+7% +$828K 0.06% 429
2015
Q2 		$13.1M Sell
86,788
-31,050
-26% -$4.44M 0.05% 447
2015
Q1 		$15.9M Sell
117,838
-6,142
-5% -$761K 0.06% 384
2014
Q4 		$14.9M Sell
123,980
-494
-0.4% -$56.9K 0.06% 391
2014
Q3 		$14.1M Buy
124,474
+24,514
+25% +$2.9M 0.06% 418
2014
Q2 		$12M Buy
+99,960
New +$12.2M 0.05% 483
2014
Q1 		– Sell
-95,959
Closed -$11.9M – 3156
2013
Q4 		$11.9M Buy
95,959
+50,430
+111% +$6.15M 0.05% 469
2013
Q3 		$5.35M Buy
45,529
+11,702
+35% +$1.38M 0.02% 874
2013
Q2 		$3.79M Buy
+33,827
New +$3.97M 0.02% 949

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Nationwide Fund Advisors's BIO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2017, closing a stake of 96,138 shares — an estimated $21.4M sold.

Nationwide Fund Advisors first reported a position in BIO in Q2 2013 and held it in 17 quarters. The position peaked at $21.4M in Q3 2017. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 96,138 Bio-Rad Laboratories Class A shares in Q4 2017, an estimated $21.4M.
  • Nationwide Fund Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Bio-Rad Laboratories Class A position peaked at $21.4M in Q3 2017.
  • 302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.